- Home
- MITQ vs ONVO Comparison
MITQ vs ONVO Comparison
Compare MITQ & ONVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MITQ
- ONVO
- Stock Information
- Founded
- MITQ N/A
- ONVO 2007
- Country
- MITQ United States
- ONVO United States
- Employees
- MITQ N/A
- ONVO N/A
- Industry
- MITQ Telecommunications Equipment
- ONVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- MITQ Telecommunications
- ONVO Health Care
- Exchange
- MITQ Nasdaq
- ONVO Nasdaq
- Market Cap
- MITQ 6.6M
- ONVO 6.5M
- IPO Year
- MITQ 2021
- ONVO N/A
- Fundamental
- Price
- MITQ $0.86
- ONVO $0.37
- Analyst Decision
- MITQ
- ONVO
- Analyst Count
- MITQ 0
- ONVO 0
- Target Price
- MITQ N/A
- ONVO N/A
- AVG Volume (30 Days)
- MITQ 4.5M
- ONVO 245.2K
- Earning Date
- MITQ 02-12-2025
- ONVO 02-06-2025
- Dividend Yield
- MITQ N/A
- ONVO N/A
- EPS Growth
- MITQ N/A
- ONVO N/A
- EPS
- MITQ N/A
- ONVO N/A
- Revenue
- MITQ $18,756,000.00
- ONVO $103,000.00
- Revenue This Year
- MITQ N/A
- ONVO $59.08
- Revenue Next Year
- MITQ N/A
- ONVO $18.24
- P/E Ratio
- MITQ N/A
- ONVO N/A
- Revenue Growth
- MITQ N/A
- ONVO N/A
- 52 Week Low
- MITQ $0.42
- ONVO $0.32
- 52 Week High
- MITQ $1.55
- ONVO $1.74
- Technical
- Relative Strength Index (RSI)
- MITQ 58.20
- ONVO 44.33
- Support Level
- MITQ $0.80
- ONVO $0.35
- Resistance Level
- MITQ $1.03
- ONVO $0.51
- Average True Range (ATR)
- MITQ 0.16
- ONVO 0.05
- MACD
- MITQ 0.01
- ONVO -0.00
- Stochastic Oscillator
- MITQ 23.84
- ONVO 13.33
About MITQ Moving iMage Technologies Inc.
Moving iMage Technologies Inc is engaged in providing designed equipment as well as other off the shelf cinema products needed for contemporary cinema requirements. It offers technical, design and consulting services such as custom engineering, systems design, integration and installation and digital technology, as well as software solutions for operations enhancement and theatre management.
About ONVO Organovo Holdings Inc.
Organovo Holdings Inc is a biotechnology company focused on developing FXR314 in inflammatory bowel disease (IBD), including ulcerative colitis (UC), based on demonstration of clinical promise in three-dimensional (3D) human tissues as well as preclinical data. FXR is a mediator of gastrointestinal and liver diseases.